Charles River Laboratories International, Inc.CRLNYSE
Loading
Book Value/Share Growth Under PressureDecelerating
Percentile Rank3
Year-over-Year Change
Year-over-year book value per share growth
Percentile
P3
Near historical low
vs 5Y Ago
-0.6x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -6.95% |
| Q3 2025 | 1.37% |
| Q2 2025 | 8.13% |
| Q1 2025 | -6.75% |
| Q4 2024 | -7.89% |
| Q3 2024 | 1.76% |
| Q2 2024 | 1.64% |
| Q1 2024 | 0.98% |
| Q4 2023 | 9.14% |
| Q3 2023 | 1.40% |
| Q3 2023 | 4.73% |
| Q2 2023 | 3.59% |
| Q4 2022 | 13.08% |
| Q3 2022 | -0.88% |
| Q2 2022 | 0.47% |
| Q1 2022 | 2.69% |
| Q4 2021 | 5.07% |
| Q3 2021 | 4.43% |
| Q2 2021 | 5.55% |
| Q1 2021 | 2.92% |
| Q4 2020 | 11.22% |
| Q3 2020 | 7.81% |
| Q2 2020 | 5.23% |
| Q1 2020 | 0.15% |
| Q4 2019 | 6.38% |
| Q3 2019 | 5.71% |
| Q2 2019 | 3.36% |
| Q1 2019 | 5.53% |
| Q4 2018 | 5.41% |
| Q3 2018 | 5.76% |
| Q2 2018 | 2.73% |
| Q1 2018 | 6.65% |
| Q4 2017 | 3.80% |
| Q3 2017 | 6.30% |
| Q3 2017 | 9.74% |
| Q2 2017 | 3.91% |
| Q4 2016 | -3.91% |
| Q3 2016 | 2.79% |
| Q2 2016 | 5.06% |
| Q1 2016 | 5.37% |